Neuromuscular Blockade
209
19
22
140
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
45 trials with published results (22%)
Research Maturity
140 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
2.9%
6 terminated out of 209 trials
95.9%
+9.3% vs benchmark
33%
70 trials in Phase 3/4
32%
45 of 140 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 140 completed trials
Clinical Trials (209)
Acceleromyography Versus Electromyography for Neuromuscular Recovery Assessment at the End of Surgery
Effect of Sarcopenia and Frailty on Rocuronium Pharmacodynamics in Geriatric Patients
Comparison of the Performances of the cTOFR and the mTOFR During Reversal of Deep Neuromuscular Blockade With Sugammadex
Comparison of Two Quantitative EMG Monitors for Deep Neuromuscular Block in Laparoscopic/Robotic and VATS Surgery
Comparison Neuromuscular Blockade Monitors
Low-Dose Rocuronium Maintenance During Spine Surgery With Intraoperative Neurophysiological Monitoring
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults
Electromyographic Calibration Guided by Depth of Anesthesia
Predicting Neuromuscular Recovery in Surgical Patients Using Machine Learning
International Focus Group Discussion on Neuromuscular Monitoring.
Sarcopenia and Neuromuscular Block in Gastrointestinal Cancer Surgery
Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in Adults
Prospective Randomized Trial of Moderate vs Deep Neuromuscular Blockade During Laparoscopic Ventral Hernia Repair
An Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and Safety
Muscle and Fat Mass in Preoperative Computed Tomography and a Neuromuscular Blocking Agent Dose
TetraGraph to Evaluate Onset and Recovery Times of Rocuronium
Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease
Understanding the Cognition and Decision Making of Community Anesthesiologists
Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison